SMITH & NEPHEW PLC -SPON ADR (SNN) Stock Price, Quote, News and Overview
NYSE:SNN - New York Stock Exchange, Inc. - US83175M2052 - ADR - Currency: USD
SNN Quote, Performance and Key Statistics
30.04
-0.24 (-0.79%)
The current stock price of SNN is 30.04 USD. In the past month the price decreased by -0.23%. In the past year, price increased by 6.19%.
SNN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.62 | 229.71B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.6 | 185.10B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.64 | 154.35B | ||
| SYK | STRYKER CORP | 31.24 | 149.60B | ||
| MDT | MEDTRONIC PLC | 16.31 | 114.97B | ||
| BDX | BECTON DICKINSON AND CO | 12.57 | 50.76B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.11 | 45.92B | ||
| IDXX | IDEXX LABORATORIES INC | 46.62 | 42.74B | ||
| RMD | RESMED INC | 27.99 | 37.26B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.18 | 34.09B | ||
| DXCM | DEXCOM INC | 51.72 | 33.46B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 14.93 | 23.15B |
Related stock screener links
About SNN
Company Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,349 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Company Info
SMITH & NEPHEW PLC -SPON ADR
Building 5, Croxley Park, Hatters Lane
Watford HERTFORDSHIRE WD18 8YE GB
CEO: Roland Diggelmann
Employees: 17349
Phone: 4401923477100
SMITH & NEPHEW PLC -SPON ADR / SNN FAQ
What is the stock price of SMITH & NEPHEW PLC -SPON ADR today?
The current stock price of SNN is 30.04 USD. The price decreased by -0.79% in the last trading session.
What is the ticker symbol for SMITH & NEPHEW PLC -SPON ADR stock?
The exchange symbol of SMITH & NEPHEW PLC -SPON ADR is SNN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is SNN stock listed?
SNN stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for SMITH & NEPHEW PLC -SPON ADR stock?
25 analysts have analysed SNN and the average price target is 34.09 USD. This implies a price increase of 13.49% is expected in the next year compared to the current price of 30.04. Check the SMITH & NEPHEW PLC -SPON ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SMITH & NEPHEW PLC -SPON ADR worth?
SMITH & NEPHEW PLC -SPON ADR (SNN) has a market capitalization of 13.14B USD. This makes SNN a Large Cap stock.
How many employees does SMITH & NEPHEW PLC -SPON ADR have?
SMITH & NEPHEW PLC -SPON ADR (SNN) currently has 17349 employees.
What are the support and resistance levels for SMITH & NEPHEW PLC -SPON ADR (SNN) stock?
SMITH & NEPHEW PLC -SPON ADR (SNN) has a support level at 29.88 and a resistance level at 31.14. Check the full technical report for a detailed analysis of SNN support and resistance levels.
Is SMITH & NEPHEW PLC -SPON ADR (SNN) expected to grow?
The Revenue of SMITH & NEPHEW PLC -SPON ADR (SNN) is expected to grow by 5.42% in the next year. Check the estimates tab for more information on the SNN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SMITH & NEPHEW PLC -SPON ADR (SNN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SNN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SNN, evaluating the profitability, health, valuation and growth aspects
- SMITH & NEPHEW PLC -SPON ADR (SNN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SMITH & NEPHEW PLC -SPON ADR (SNN) Sales and EPS estimates to see what analysts future expectations are.
- SMITH & NEPHEW PLC -SPON ADR (SNN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SMITH & NEPHEW PLC -SPON ADR (SNN) Insider and Institutional Ownership to learn about the owners and their transactions.
- SMITH & NEPHEW PLC -SPON ADR (SNN) Stock Chart to make your own analysis
- SMITH & NEPHEW PLC -SPON ADR (SNN) Latest news and press-releases to stay up to date.
Does SMITH & NEPHEW PLC -SPON ADR (SNN) stock pay dividends?
SMITH & NEPHEW PLC -SPON ADR (SNN) has a dividend yield of 2.47%. The yearly dividend amount is currently 0.37. Check the full fundamental report for a detailed analysis of SNN dividend history, reliability and sustainability.
When does SMITH & NEPHEW PLC -SPON ADR (SNN) report earnings?
SMITH & NEPHEW PLC -SPON ADR (SNN) will report earnings on 2025-08-05.
What is the Price/Earnings (PE) ratio of SMITH & NEPHEW PLC -SPON ADR (SNN)?
The PE ratio for SMITH & NEPHEW PLC -SPON ADR (SNN) is 31.96. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 30.04 USD. Check the full fundamental report for a full analysis of the valuation metrics for SNN.
What is the Short Interest ratio of SMITH & NEPHEW PLC -SPON ADR (SNN) stock?
The outstanding short interest for SMITH & NEPHEW PLC -SPON ADR (SNN) is 0.57% of its float. Check the ownership tab for more information on the SNN short interest.
SNN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to SNN. When comparing the yearly performance of all stocks, SNN turns out to be only a medium performer in the overall market: it outperformed 60.62% of all stocks.
SNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SNN. While SNN has a great profitability rating, there are some minor concerns on its financial health.
SNN Financial Highlights
Over the last trailing twelve months SNN reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS increased by 56.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.09% | ||
| ROA | 3.98% | ||
| ROE | 7.83% | ||
| Debt/Equity | 0.62 |
SNN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to SNN. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 16.67% and a revenue growth 5.42% for SNN